$VXRT Global market for Influenza vaccines last year nearly 4.5b and expected at nearly 8b by 2027. Influenza vaccine is VXRT niche in the industry and positioned to possibly disrupt established delivery and administration of the flu vaccine forever. COVID, unfortunately but fortunately is the catalyst which has moved research and trials along at break neck speed. COVID vaccine is welcome and needed immediately but yearly flu vaccines (oral) will be the standard soon. Already proven safer and more effective than the leading flu vaccine (injected) ala Fluzone. Stay strong! fortunebusinessinsights.com...
  • 3